Evidence map›Paper›PMID 37733078›Full record

ArticleClinical rheumatology2024

Mortality and Ankylosing Spondylitis in the US population: leading causes and associated factors.

Mohamad Bittar, Simonne S Nouer, Elizabeth A Tolley, Maureen Dubreuil, Marina Magrey

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mohamad BittarDivision of Connective Tissue Disease (Rheumatology), The University of Tennessee Health Science Center, Memphis, TN, USA. bittarmohamad1989@gmail.com.ORCID http://orcid.org/0000-0001-9283-7462
Simonne S NouerDepartment of Preventive Medicine (Biostatistics and Epidemiology), The University of Tennessee Health Science Center, Memphis, TN, USA.
Elizabeth A TolleyDepartment of Preventive Medicine (Biostatistics and Epidemiology), The University of Tennessee Health Science Center, Memphis, TN, USA.
Maureen DubreuilSection of Rheumatology, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Marina MagreyDivision of Rheumatology, University Hospitals/Case Western Reserve University, Cleveland, OH, USA.
University of Tennessee Health Science Center · USBoston University · USUniversity Hospitals of Cleveland · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAnkylosing Spondylitis (AS) is a chronic inflammatory condition that affects the axial skeleton. Recent studies have shown that mortality risk is higher in AS patients and that it is possibly related to disease activity and duration. Our aim was to investigate the leading causes and factors associated with mortality in hospitalized AS patients in the USA.

methodsThis is a case-control study using the Cerner Health Facts® database between 2015 and 2017. The search was done using ICD codes and administrative claims. Cases were hospitalized AS patients who died during that hospitalization, while controls were patients who survived. In addition to demographics, we collected data on the inpatient use of medications such as NSAIDs, as well as different comorbidities and systemic disease manifestations. The discharge diagnoses for deceased patients were collected to infer causes of mortality. Analysis of association was performed using chi-square tests, t-tests, Wilcoxon rank-sum tests, and logistic regression methods.

resultsThe leading causes of death were cardiovascular, infectious, respiratory, and traumatic. The Elixhauser comorbidity index was the factor most associated with mortality (p-value < 0.0001), with congestive heart failure and renal disease the most contributing. Drug use disorder was associated with mortality (adjusted OR = 10.9; p = 0.001). Inpatient NSAIDs use was not associated with increased odds for mortality (p-value 0.33).

conclusionCardiovascular and renal comorbidities are associated with mortality and need to be targeted early on to lower the odds of mortality as patients age. Strategies to prevent opioid and drug abuse should be strengthened in the AS population. Key Points • Cardiovascular and renal comorbidities are associated with mortality and need to be screened for and targeted early on to lower the odds of mortality as patients age. • Drug use disorder including opioid dependence is associated with mortality, and strategies to prevent opioid and drug abuse should be strengthened in the AS population.

Indexed as

Opioid-Related DisordersSpondylitis, AnkylosingAnalgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalCase-Control StudiesHumansAnalgesics, OpioidAnti-Inflammatory Agents, Non-SteroidalAnkylosing SpondylitisAxial SpondyloarthritisEpidemiologyMortalityOutcomes

Identifiers

PMID37733078
OpenAlexW4386910309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.